Jim Simons Kamada LTD Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Kamada LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 856,106 shares of KMDA stock, worth $5.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

856,106

Previous 836,305 2.37%

Holding current value

$5.16 Million

Previous $4.15 Million 10.82%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.83 - $6.25 $95,638 - $123,756	19,801 Added 2.37%	856,106 $4.6 Million
Q2 2024 Aug 09, 2024	SELL	$4.78 - $5.75 $53,058 - $63,825	-11,100 Reduced 1.31%	836,305 $4.15 Million
Q1 2024 May 13, 2024	SELL	$5.58 - $6.42 $61,145 - $70,350	-10,958 Reduced 1.28%	847,405 $4.75 Million
Q4 2023 Feb 13, 2024	SELL	$4.14 - $6.22 $33,707 - $50,643	-8,142 Reduced 0.94%	858,363 $5.25 Million
Q3 2023 Nov 14, 2023	SELL	$4.86 - $5.83 $24,300 - $29,150	-5,000 Reduced 0.57%	866,505 $4.63 Million
Q2 2023 Aug 11, 2023	BUY	$4.48 - $5.53 $99,904 - $123,319	22,300 Added 2.63%	871,505 $4.6 Million
Q1 2023 May 12, 2023	SELL	$4.12 - $5.25 $26,120 - $33,285	-6,340 Reduced 0.74%	849,205 $3.95 Million
Q4 2022 Feb 13, 2023	SELL	$3.79 - $4.84 $93,992 - $120,032	-24,800 Reduced 2.82%	855,545 $3.43 Million
Q3 2022 Nov 14, 2022	SELL	$4.42 - $5.43 $186,966 - $229,689	-42,300 Reduced 4.58%	880,345 $3.97 Million
Q2 2022 Aug 12, 2022	SELL	$4.22 - $5.85 $10,972 - $15,209	-2,600 Reduced 0.28%	922,645 $4.16 Million
Q1 2022 May 13, 2022	SELL	$5.43 - $6.81 $122,175 - $153,225	-22,500 Reduced 2.37%	925,245 $5.11 Million
Q4 2021 Feb 11, 2022	SELL	$5.21 - $6.82 $323,541 - $423,522	-62,100 Reduced 6.15%	947,745 $6.24 Million
Q3 2021 Nov 12, 2021	SELL	$5.25 - $5.87 $585,889 - $655,080	-111,598 Reduced 9.95%	1,009,845 $5.35 Million
Q2 2021 Aug 13, 2021	SELL	$5.67 - $6.33 $520,517 - $581,106	-91,802 Reduced 7.57%	1,121,443 $6.53 Million
Q1 2021 May 13, 2021	SELL	$6.02 - $8.06 $210,097 - $281,294	-34,900 Reduced 2.8%	1,213,245 $7.51 Million
Q4 2020 Feb 10, 2021	BUY	$6.3 - $8.46 $527,940 - $708,948	83,800 Added 7.2%	1,248,145 $8.09 Million
Q3 2020 Nov 13, 2020	BUY	$8.02 - $11.73 $195,688 - $286,212	24,400 Added 2.14%	1,164,345 $9.73 Million
Q2 2020 Aug 13, 2020	BUY	$5.37 - $9.45 $857,470 - $1.51 Million	159,678 Added 16.29%	1,139,945 $8.85 Million
Q1 2020 May 14, 2020	BUY	$4.56 - $7.13 $193,517 - $302,582	42,438 Added 4.53%	980,267 $5.72 Million
Q4 2019 Feb 13, 2020	BUY	$4.97 - $7.7 $534,796 - $828,558	107,605 Added 12.96%	937,829 $6.41 Million
Q3 2019 Nov 13, 2019	BUY	$5.11 - $5.99 $157,934 - $185,132	30,907 Added 3.87%	830,224 $4.26 Million
Q2 2019 Aug 12, 2019	BUY	$5.39 - $6.26 $484,345 - $562,523	89,860 Added 12.67%	799,317 $4.41 Million
Q1 2019 May 14, 2019	BUY	$5.12 - $6.18 $864,399 - $1.04 Million	168,828 Added 31.23%	709,457 $4.07 Million
Q4 2018 Feb 13, 2019	BUY	$4.68 - $6.25 $2.53 Million - $3.38 Million	540,629 New	540,629 $2.7 Million

Others Institutions Holding KMDA

# of Institutions

Shares Held

6.18M

Call Options Held

2.2K

Put Options Held

63.8K

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $270M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account